CA2415214C - Phosphotetrahydropyran compounds - Google Patents

Phosphotetrahydropyran compounds Download PDF

Info

Publication number
CA2415214C
CA2415214C CA002415214A CA2415214A CA2415214C CA 2415214 C CA2415214 C CA 2415214C CA 002415214 A CA002415214 A CA 002415214A CA 2415214 A CA2415214 A CA 2415214A CA 2415214 C CA2415214 C CA 2415214C
Authority
CA
Canada
Prior art keywords
alkyl
disease
pyran
tetrahydro
aryl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA002415214A
Other languages
English (en)
French (fr)
Other versions
CA2415214A1 (en
Inventor
William Butler Cowden
Bart Michael Eschler
Darren Ray March
Douglas John Francis
Sendaba Gerba
Gavin James Bartell
Brett Charlton
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmaxis Ltd
Original Assignee
Pharmaxis Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmaxis Ltd filed Critical Pharmaxis Ltd
Publication of CA2415214A1 publication Critical patent/CA2415214A1/en
Application granted granted Critical
Publication of CA2415214C publication Critical patent/CA2415214C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H11/00—Compounds containing saccharide radicals esterified by inorganic acids; Metal salts thereof
    • C07H11/04—Phosphates; Phosphites; Polyphosphates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/655—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms
    • C07F9/6552—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a six-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6558—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
    • C07F9/65586—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system at least one of the hetero rings does not contain nitrogen as ring hetero atom

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Dermatology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Rheumatology (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Ophthalmology & Optometry (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Biomedical Technology (AREA)
  • Pulmonology (AREA)
  • Emergency Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Transplantation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
CA002415214A 2000-07-11 2001-07-11 Phosphotetrahydropyran compounds Expired - Fee Related CA2415214C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AUPQ8723 2000-07-11
AUPQ8723A AUPQ872300A0 (en) 2000-07-11 2000-07-11 Compounds and methods
PCT/AU2001/000831 WO2002004472A1 (en) 2000-07-11 2001-07-11 Novel compounds and methods

Publications (2)

Publication Number Publication Date
CA2415214A1 CA2415214A1 (en) 2002-01-17
CA2415214C true CA2415214C (en) 2009-12-22

Family

ID=3822788

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002415214A Expired - Fee Related CA2415214C (en) 2000-07-11 2001-07-11 Phosphotetrahydropyran compounds

Country Status (7)

Country Link
US (1) US6878690B2 (cg-RX-API-DMAC7.html)
EP (1) EP1301522A4 (cg-RX-API-DMAC7.html)
JP (1) JP5035940B2 (cg-RX-API-DMAC7.html)
AU (1) AUPQ872300A0 (cg-RX-API-DMAC7.html)
CA (1) CA2415214C (cg-RX-API-DMAC7.html)
NZ (1) NZ523565A (cg-RX-API-DMAC7.html)
WO (1) WO2002004472A1 (cg-RX-API-DMAC7.html)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1628987E (pt) 2003-05-20 2009-10-29 Pharmaxis Pty Ltd Compostos manose-6-fosfonato para o tratamento de doenças inflamatórias
BRPI0411691A (pt) * 2003-07-02 2006-12-26 Teva Gyogyszergyar Reszvenytar l-lisina de aztreonam e seus métodos de preparação
US20080057072A1 (en) * 2006-08-31 2008-03-06 Alcon Manufacturing, Ltd. Antagonists of ci-m6p/igf2r for prevention and treatment of ctgf-mediated ocular disorders
JP2012525369A (ja) * 2009-04-28 2012-10-22 ファーマキシス リミテッド 創傷および線維性障害の治療のためのホスホテトラヒドロピラン化合物
FR2992647B1 (fr) * 2012-07-02 2016-04-01 Centre Nat Rech Scient Derives de glycosides, leur preparation et leur utilisation comme groupes prosthetiques
NZ708928A (en) 2012-12-18 2020-04-24 Vertex Pharma Mannose derivatives for treating bacterial infections
AU2014248717B2 (en) 2013-03-12 2018-03-29 Vertex Pharmaceuticals Incorporated Mannose derivatives for treating bacterial infections
WO2016151989A1 (en) * 2015-03-24 2016-09-29 Okinawa Institute Of Science And Technology School Corporation C-glycoside derivatives
EP3959220A1 (en) * 2019-04-26 2022-03-02 Shanghai Yao Yuan Biotechnology Co., Ltd. Derivatives of glycero-manno-heptose phosphate and their use in modulating an immune response
CN112315950A (zh) * 2020-12-25 2021-02-05 西北农林科技大学 苯丙氨酸在制备防治葛根素注射剂诱发的血管内溶血的药物上的应用
CN113563136A (zh) * 2021-07-01 2021-10-29 胡国府 一种可溶性固态缓释肥料剂及其施用方法
CN116272899B (zh) * 2023-03-01 2025-04-04 西安理工大学 一种鳞片状中空纤维气凝胶的制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5506210A (en) 1988-08-19 1996-04-09 The Australian National University Phosphosugar-based anti-inflammatory and/or immunosuppressive drugs
GB9516012D0 (en) * 1995-08-04 1995-10-04 Univ Manchester Pharmaceutical composition
AUPO309896A0 (en) 1996-10-18 1996-11-14 Australian National University, The Novel phosphosugars and phosphosugar-containing compounds having anti-inflammatory activity
GB9626450D0 (en) * 1996-12-20 1997-02-05 Oxford Glycosciences Uk Ltd Therapeutic compounds

Also Published As

Publication number Publication date
AUPQ872300A0 (en) 2000-08-03
EP1301522A1 (en) 2003-04-16
JP2004501985A (ja) 2004-01-22
JP5035940B2 (ja) 2012-09-26
NZ523565A (en) 2004-03-26
EP1301522A4 (en) 2004-04-14
WO2002004472A1 (en) 2002-01-17
US6878690B2 (en) 2005-04-12
US20030176363A1 (en) 2003-09-18
CA2415214A1 (en) 2002-01-17

Similar Documents

Publication Publication Date Title
AU651835B2 (en) Phosphorous prodrugs
US6878690B2 (en) Compounds and methods
CA1338627C (en) Pharmaceuticals based on phosphoric acid esters for use in tumor therapy, and process for their preparation
US5369097A (en) Phosphonates as anti-cancer agents
CN100384820C (zh) 氟羟吲哚的磷酸酯前体药物
US4804789A (en) D-mannite derivatives as starting products for the synthesis of phospholipids
US20140171394A1 (en) Cyclitols and their derivatives and their therapeutic applications
US5424441A (en) N-aralkyl-and N-heteroaralkyl-aminoalkanephosphinic acids
Herrin et al. Synthesis and anti-herpes simplex activity of analogs of phosphonoacetic acid
US5376684A (en) Aminoalkanephosphinic acids and salts thereof
KR101327635B1 (ko) 포스폰산화 리파마이신, 및 그의 뼈 및 관절 감염의 저지및 치료 용도
EP0570706A1 (en) Aryl and heteroaryl (phosphinylmethyl) phosphonate squalene synthetase inhibitors and method
EP0787135B1 (fr) Derives hydrosolubles d'epipodophyllotoxine, leur procede de preparation, leur utilisation a titre de medicament, et leur utilisation destinee aux traitements anticancereux
AU2001270356B2 (en) Novel compounds and methods
AU2001270356A1 (en) Novel compounds and methods
PT97407B (pt) Processo para a preparacao de (r)-9-{2-(fosfono-metoxi)-propil}-guanina
US5219845A (en) Phosphonates as anti-inflammation agents
CA2511753C (en) Phospholipid derivatives
EP1506208A2 (en) 1,1- and 1,2-bisphosphonates as apolipoprotein e modulators
KR20080028358A (ko) 포스폰산화 플루오로퀴놀론, 그의 항박테리아 유사체, 및뼈 및 관절 감염의 저지 및 치료 방법
US5916884A (en) Compositions containing a mixture of phosphorus compounds and alkylglycerols
CA2525328C (en) Novel phosphotetrahydropyrans and methods
WO1992019627A2 (en) Phosphonates and phosphinates as anti-cancer, -inflammatory, -allergy and -myocarditis agents
AU2012242652A1 (en) Bicyclic methyl amine derivatives as sphingosine-1 phosphate receptors modulators
EP1019418B1 (en) Inositol derivatives and pharmaceutical compositions comprising them

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed

Effective date: 20140711